Dermatological Cannabinoid Formulation Targets Severe Skin and Mucosal Inflammation
The patent application describes a topical cream or ointment designed to modulate peripheral CB1 and CB2 receptors using botanical extracts. Formulations aim to address musculoskeletal discomfort, peripheral nerve irritation, and pruritus alongside…
CB2 Receptors in the Brain: A Promising but Unproven Anti-Inflammatory Target
CB2 receptor neuroinflammation is a promising target in neurodegenerative diseases such as Alzheimer's and Parkinson's. Preclinical studies show CB2 activation reduces brain inflammation and protects neurons. However, clinical evidence for CB2 receptor…
Cannabis and Inflammation: Clinical Mechanisms
Cannabis anti-inflammatory mechanisms involve THC and CBD interacting with cannabinoid receptors to reduce inflammatory markers. These mechanisms modulate cytokines such as TNF-alpha, IL-6, and IL-8. Understanding these pathways supports clinical…
The Role of Cannabinoid CB2 Receptors in Trauma-Induced Anxiety and PTSD
Cannabinoid CB2 receptors anxiety regulation plays a key role in trauma-induced anxiety and PTSD. Activation of CB2 receptors shows anxiolytic effects in animal models. This receptor system is a promising target for PTSD drug research.
Cannabinoid receptor type 2 as a promising new target for schizophrenia drugs
Cannabinoid receptor type 2 schizophrenia roles are crucial in regulating symptoms like anxiety, depression, and cognitive impairments. This receptor influences various schizophrenia-related behaviors in animal models. Understanding CB2's impact offers…
